Protein-Folding Chaperones Predict Structure-Function Relationships and Cancer Risk in BRCA1 Mutation Carriers
Description
We used a high-throughput LUMIER assay to test whether the binding patterns of protein-folding chaperones can be used to predict structure-function relationships of BRCA1 variants and the clinical manifestations of BRCA1 mutations in carriers. Our findings are presented in the following tables. Table S1. Chaperone binding detects BRCA1-BRCT pathogenic ClinVar variants and rationally designed variants that disrupt domain structure Table S2. Computational analysis of thermodynamic stability for pathogenic BRCA1-BRCT missense mutations in ClinVar Table S3. Diverse functional outcomes of BRCA1-BRCT variants detected by chaperone binding Table S4. Features of human hypomorphic BRCA1 variants characterized by chaperones Table S5. Human BRCA1 carriers exhibiting early disease onset identified by chaperone binding
Files
Institutions
Categories
Funding
NCI
K22CA222938
Cancer Prevention and Research Institute of Texas
RR180005
NCI
F32CA253780